Skip to main content

Table 1 Clinical characteristics of the sample

From: Association of common variants in JAK2 gene with reduced risk of metabolic syndrome and related disorders

 

Mean

SD

Phenotype

Prevalence (%)

Age (yr)

37.11

10.91

HTG

31.1

BMI (kg/m2)

28.20

4.40

HW

27.8

WC (cm)

96.15

12.26

Decreased HDL-C

45.6

SBP (mmHg)

126.29

11.02

Abdominal obesity

31.3

DBP (mmHg)

80.11

7.38

Obesity

29.3

TC (mg/dl)

187.45

40.75

IFG

18.0

LDL-C (mg/dl)

118.52

34.89

MS

24.1

HDL-C (mg/dl)

41.25

10.66

  

TG (mg/dl)

138.77

95.97

  

LAP

52.74

6.72

  

TG/HDL-C

3.86

3.73

  

FPG (mg/dl)

91.87

12.23

  

Fasting insulin

16.18

9.27

  

HOMA-IR

2.07

1.16

  
  1. n = 724. DBP, diastolic blood pressure; FPG, fasting plasma glucose; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance; HW, hypertriglyceridemic waist; IR, insulin resistance; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure; TC, total cholesterol; TG, triglycerides; LAP = lipid accumulation product; WC, waist circumference; HTG = Hypertriglyceridemia; HW = hypertriglyceridemic waist; IFG = impaired fasting glucosa; MS = metabolic syndrome